Liu Yizhou, Cheney Matthew D, Gaudet Justin J, Chruszcz Maksymilian, Lukasik Stephen M, Sugiyama Daisuke, Lary Jeff, Cole James, Dauter Zbyszek, Minor Wladek, Speck Nancy A, Bushweller John H
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia 22908, USA.
Cancer Cell. 2006 Apr;9(4):249-60. doi: 10.1016/j.ccr.2006.03.012.
AML1/ETO is the chimeric protein resulting from the t(8;21) in acute myeloid leukemia. The Nervy homology 2 (NHR2) domain in ETO mediates oligomerization and AML1/ETO's interactions with ETO, MTGR1, and MTG16, and with the corepressor molecules mSin3A and HDAC1 and HDAC3. We solved the NHR2 domain structure and found it to be an alpha-helical tetramer. We show that oligomerization contributes to AML1/ETO's inhibition of granulocyte differentiation, is essential for its ability to enhance the clonogenic potential of primary mouse bone marrow cells, and affects AML1/ETO's activity on several endogenous genes. Oligomerization is also required for AML1/ETO's interactions with ETO, MTGR1, and MTG16, but not with other corepressor molecules.
AML1/ETO是急性髓系白血病中由t(8;21)产生的嵌合蛋白。ETO中的神经同源2(NHR2)结构域介导寡聚化以及AML1/ETO与ETO、MTGR1和MTG16的相互作用,以及与共抑制分子mSin3A、HDAC1和HDAC3的相互作用。我们解析了NHR2结构域的结构,发现它是一个α螺旋四聚体。我们表明,寡聚化有助于AML1/ETO抑制粒细胞分化,对其增强原代小鼠骨髓细胞克隆形成潜力的能力至关重要,并影响AML1/ETO对多个内源性基因的活性。寡聚化也是AML1/ETO与ETO、MTGR1和MTG16相互作用所必需的,但与其他共抑制分子的相互作用则不需要。